register

News & Trends - Pharmaceuticals

Australian researchers collaborate with Janssen to accelerate cancer treatment

Health Industry Hub | June 20, 2022 |
[Total: 2    Average: 4.5/5]

Pharma News: Australian researchers will fast-track research into potential new lung cancer drug treatments through a strategic collaboration with Janssen, facilitated by the Johnson & Johnson Innovation Partnering Office.

The Queensland University of Technology (QUT) research team, led by Professor Derek Richard, have been given access to the Janssen Jump-stARTer Compound Library, a unique and highly curated collection of 80,000 chemical compounds, which may allow the researchers to hasten identifying potential promising drug candidates and advancing their development.

Lung cancer is the fifth most commonly diagnosed cancer and the most common cause of cancer death in Australia.

Vice-President of Business Development Professor Mark Harvey welcomed the announcement and said the QUT research team would be using high-tech robotic devices to screen potential drug candidates.

“The Jump-stARTer Compound Library is a world class molecule library, and this strategic collaboration will potentially reduce the time needed to identify promising new drug candidates, it epitomises the real-world research approach at QUT,” Professor Harvey said.

Kathy Connell, Senior Director, Early Innovation Partnering, Australia & New Zealand Johnson & Johnson Innovation, told Health Industry Hub “This collaboration with the QUT research team is especially meaningful as it aims to fast-track research into potentially new lung cancer drug treatments through our Jump-stARTer Compound Library. Lung cancer remains the most common cause of cancer death in Australia and access to this library will allow researchers an opportunity to use high-tech robotic devices to screen potential promising drug candidates. I am incredibly excited by the potential of this strategic partnership and to help advance scientific innovation that could positively impact the lives of patients around the world.”

AstraZeneca-UNSW partner to boost the Australian startup ecosystem

Professor Harvey added “Collaborations like this, along with the use of cutting-edge robotic screening technologies, will help drive significant changes in medicine in the next few decades and we look forward to the continued opportunities our researchers will have in working on real-world projects with collaborators.”

Johnson & Johnson Innovation has facilitated a collaboration between Australian’s Walter and Eliza Hall Institute of Medical Research (WEHI) and Janssen to ignite the development of antimalarial drug candidates using the Jump-stARTer Compound Library.

Janssen has also teamed up with Monash University to discover and develop biologic next-generation therapeutics for rheumatoid arthritis. Janssen and Monash have formed a multiyear collaboration and have pre-negotiated an option-to-license agreement.


Human Resources

Only 29% of employees say their leader shows ‘human leadership’

Health Industry Hub | June 24, 2022 |

Human Resources: A survey of more than 230 HR leaders revealed that 90% believe that to succeed in today’s work environment, […]

More


News & Trends - Medical Technology

MedTech News - Quantum HealthCare appointed as ANZ distributor for new medical technology

Quantum HealthCare appointed as ANZ distributor for new medical technology

Health Industry Hub | June 24, 2022 |

MedTech News: Alfred Health Hospital in Australia is set to receive first-in-nation portable MRI systems for point-of-care brain scans. US-based […]

More


News & Trends - Medical Technology

Medtech News - Medical association continues its strong opposition to Honeysuckle Health in legal proceedings

Medical association continues its strong opposition to Honeysuckle Health in legal proceedings

Health Industry Hub | June 24, 2022 |

MedTech News: The Australian Medical Association (AMA) is involved in proceedings before the Australian Competition Tribunal, opposing an attempt by […]

More


News & Trends - Medical Technology

Medtech News -

Medtronic award winner secures approval in diagnosis of gut disorders

Health Industry Hub | June 24, 2022 |

MedTech News: New Zealand based company and winner of the inaugural Medtronic APAC Innovation Challenge (MAIC) has received FDA approval […]

More


This content is copyright protected